The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Vaughn James J since year 2005.
The trader's CIK number is 1649689.
At the time of this reporting, Vaughn James J is the Chief Commercial Officer of Genomic Health Inc .
(stock ticker symbol GHDX).
See this page for all insider trading activities at Genomic Health Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-01-02||GHDX||Genomic Health Inc||Option Ex||2,169||17.33||37,588|
|2018-01-02||GHDX||Genomic Health Inc||Sale||3,004||34.09||102,406|
|2017-11-01||GHDX||Genomic Health Inc||Option Ex||3,907||17.33||67,708|
|2017-11-02||GHDX||Genomic Health Inc||Option Ex||924||17.33||16,012|
|2017-11-01||GHDX||Genomic Health Inc||Sale||5,617||32.58||183,007|
|2017-11-02||GHDX||Genomic Health Inc||Sale||1,379||32.51||44,824|
|2017-08-08||GHDX||Genomic Health Inc||Option Ex||6,500||23.31||151,515|
|2017-08-08||GHDX||Genomic Health Inc||Sale||8,000||30.59||244,728|
|2016-10-06||GHDX||Genomic Health Inc||Sale||3,000||29.68||89,043|
|2016-08-08||GHDX||Genomic Health Inc||Sale||3,000||28.74||86,223|
|2016-06-06||GHDX||Genomic Health Inc||Sale||1,997||28.00||55,916|
|2016-06-06||GHDX||Genomic Health Inc||Option Ex||1,997||18.89||37,723|
|2016-05-09||GHDX||Genomic Health Inc||Sale||2,000||28.00||56,000|
|2016-05-09||GHDX||Genomic Health Inc||Option Ex||2,000||18.89||37,780|
|2016-01-07||GHDX||Genomic Health Inc||Option Ex||2,000||18.89||37,780|
|2016-01-07||GHDX||Genomic Health Inc||Sale||2,000||33.63||67,266|
|2015-12-07||GHDX||Genomic Health Inc||Option Ex||2,000||18.89||37,780|
|2015-12-07||GHDX||Genomic Health Inc||Sale||2,000||29.33||58,668|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Vaughn James J (Chief Commercial Officer of Genomic Health Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.